Thomas J. Schaefer - 03 Jan 2023 Form 3 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Reporting relationship: Chief Financial Officer
Issuer ticker: RKDA
Reported as of: 03 Jan 2023
Net transaction value: $0
SEC form: 3
Accepted by SEC: 05 Jan 2023, 19:47:21 UTC
Next SEC filing: 02 Feb 2023
Source filing: View source filing
Reporting owner signature: Thomas Schaefer, by Attorney-in-fact, Solaeta Chan

Key filing fact

Thomas J. Schaefer filed Form 3 for Arcadia Biosciences, Inc. (RKDA) on 05 Jan 2023.

Key facts

This page summarizes Thomas J. Schaefer's Form 3 filing for Arcadia Biosciences, Inc. (RKDA).
0 reported transactions and 6 derivative rows are listed below.
Accepted by SEC: 05 Jan 2023, 19:47.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RKDA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,100
Date: 03 Jan 2023
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RKDA holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 03 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,000
Exercise price: $3.67
Footnotes: F1

RKDA holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 03 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,000
Exercise price: $3.05
Footnotes: F2

RKDA holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 03 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,000
Exercise price: $2.09
Footnotes: F3

RKDA holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 03 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 23,000
Exercise price: $1.27
Footnotes: F4

RKDA holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 03 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 31,000
Exercise price: $1.27
Footnotes: F5

RKDA holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 03 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 23,000
Exercise price: $0.9400
Footnotes: F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The options were granted on 7/27/2020 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.

Footnote F2

The options were granted on 1/21/2021 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.

Footnote F3

The options will vest monthly in equal installments over a period of four years from the date of the grant, 10/1/2021, subject to the Participant's continued service.

Footnote F4

The options will vest annually in equal installments over a period of two years from the date of the grant, 4/11/2022, subject to the Participant's continued service.

Footnote F5

The options were granted on 4/11/2022 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.

Footnote F6

The options will vest annually in equal installments over a period of three years from the date of the grant, 8/16/2022, subject to the Participant's continued service.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .